GlassScriptPhysician profile
Richard G Reish
NPI 1023282829
$114,966.02
in general payments reported to CMS, 2019-2025
13 companies · $73K in 2025
The $73K reported for 2025 was more than what 99% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,204 · 2020: $162 · 2021: $227 · 2022: $918 · 2023: $1,201 · 2024: $39K · 2025: $73K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $97K · Travel and Lodging: $10K · Food and Beverage: $3,554 · Grant: $1,381 · Entertainment: $59.93 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $97,350.00 |
| Travel and Lodging | $10,055.82 |
| Food and Beverage | $3,554.29 |
| Grant | $1,380.95 |
| Entertainment | $59.93 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $53.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Musculoskeletal Transplant Foundation INC. | $109,854.39 | 2021-2025 | |
| Allergan, INC. | $1,555.29 | 2019-2022 | |
| Abbvie INC. | $1,506.43 | 2023-2025 | |
| Motiva USA, LLC | $529.46 | 2025 | |
| Davol INC. | $520.62 | 2022-2025 | Phasix Mesh |
| Tepha INC | $411.30 | 2019 | |
| Medtronic USA, INC. | $150.00 | 2020 | |
| Sientra, INC. | $138.53 | 2020-2021 | |
| Mentor Worldwide LLC | $134.79 | 2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Convatec INC. | $67.38 | 2023-2024 | |
| Merz North America, INC. | $41.77 | 2023-2024 | Xeomin |
| Tela Bio, INC. | $33.74 | 2024 | Ovitex 2s |
| Hydrofera LLC | $22.32 | 2024 | Hydrofera Blue Ready - Border |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Reish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.